Cleared Traditional

K781306 - UREA NITROGEN TEST KIT

K781306 is an FDA 510(k) clearance for UREA NITROGEN TEST KIT, manufactured by Analytical & Research Chemicals, Inc.. The device is a Class 2 Chemistry device with product code CDL cleared through the Traditional 510(k) pathway after a 34-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1978
Decision
34d
Days
Class 2
Risk

K781306 is an FDA 510(k) clearance for the UREA NITROGEN TEST KIT. Classified as Berthelot Indophenol, Urea Nitrogen (product code CDL), Class II - Special Controls.

Submitted by Analytical & Research Chemicals, Inc. (Mchenry, US). The FDA issued a Cleared decision on August 31, 1978 after a review of 34 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1770 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K781306

510(k) Number K781306 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 28, 1978
Decision Date August 31, 1978
Days to Decision 34 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
55d faster than avg
Panel avg: 89d · This submission: 34d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CDL Device Classification - Class 2, Special Controls

Product Code CDL Berthelot Indophenol, Urea Nitrogen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.